Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Explicit Assessment of Thromboembolic Risk and Prophylaxis for Medical Patients in Switzerland

This study has been completed.
Sponsor:
Collaborators:
University Hospital Inselspital, Berne
Kantonsspital Baden
University of Zurich
Luzerner Kantonsspital
Cantonal Hospital of St. Gallen
Sanofi
Information provided by (Responsible Party):
Mathieu R NENDAZ, University Hospital, Geneva
ClinicalTrials.gov Identifier:
NCT01277536
First received: January 14, 2011
Last updated: March 17, 2014
Last verified: March 2014